Update on orthokeratology in managing progressive myopia in children: Efficacy, mechanisms, and concerns

Xintong Li, Ilana B. Friedman, Norman B. Medow, Cheng Zhang

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Myopia is an important public health issue, and high myopia may lead to severe complications if left untreated. Orthokeratology lenses, worn overnight to reshape the cornea, are one of many recent modalities used to slow down the progression of myopia in children. This treatment has been proven successful, as evidenced by decreased spherical refractive error and axial length relative to the control at interval follow-up ranging from 6 months to 5 years. In this systematic review, the authors collected published controlled studies that analyzed the efficacy of orthokeratology lens wear and calculated longitudinal relative changes in axial length, revealing a weighted average of -45.1% change in axial length at the 2-year follow-up. The exact mechanism by which orthokeratology lenses reduce myopia progression is unknown, but research shows that the corneal reshaping decreases peripheral hyperopic defocus and therefore increases peripheral myopic defocus to likely reduce stimuli for axial elongation and subsequent development of myopia. Use of orthokeratology lenses is generally safe, but cases of associated infectious keratitis may have a higher incidence of virulent organisms such as Pseudomonas, Acanthamoeba, and antibacterial-resistant strains of Staphylococcus, partially due to the required overnight use of these lenses. Orthokeratology is regarded as one of the most effective non-pharmacologic measures to slow progression of myopia in children and, with regular follow-up to ensure safety, continues to be one of the most effective treatments for myopia management around the world.

Original languageEnglish (US)
Pages (from-to)142-148
Number of pages7
JournalJournal of Pediatric Ophthalmology and Strabismus
Volume54
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Degenerative Myopia
Myopia
Lenses
Acanthamoeba
Refractive Errors
Keratitis
Pseudomonas
Staphylococcus
Cornea
Public Health
Safety
Incidence

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)
  • Ophthalmology

Cite this

Update on orthokeratology in managing progressive myopia in children : Efficacy, mechanisms, and concerns. / Li, Xintong; Friedman, Ilana B.; Medow, Norman B.; Zhang, Cheng.

In: Journal of Pediatric Ophthalmology and Strabismus, Vol. 54, No. 3, 01.05.2017, p. 142-148.

Research output: Contribution to journalReview article

@article{1d8fea6d5cbe464d8653f6e1c55676ff,
title = "Update on orthokeratology in managing progressive myopia in children: Efficacy, mechanisms, and concerns",
abstract = "Myopia is an important public health issue, and high myopia may lead to severe complications if left untreated. Orthokeratology lenses, worn overnight to reshape the cornea, are one of many recent modalities used to slow down the progression of myopia in children. This treatment has been proven successful, as evidenced by decreased spherical refractive error and axial length relative to the control at interval follow-up ranging from 6 months to 5 years. In this systematic review, the authors collected published controlled studies that analyzed the efficacy of orthokeratology lens wear and calculated longitudinal relative changes in axial length, revealing a weighted average of -45.1{\%} change in axial length at the 2-year follow-up. The exact mechanism by which orthokeratology lenses reduce myopia progression is unknown, but research shows that the corneal reshaping decreases peripheral hyperopic defocus and therefore increases peripheral myopic defocus to likely reduce stimuli for axial elongation and subsequent development of myopia. Use of orthokeratology lenses is generally safe, but cases of associated infectious keratitis may have a higher incidence of virulent organisms such as Pseudomonas, Acanthamoeba, and antibacterial-resistant strains of Staphylococcus, partially due to the required overnight use of these lenses. Orthokeratology is regarded as one of the most effective non-pharmacologic measures to slow progression of myopia in children and, with regular follow-up to ensure safety, continues to be one of the most effective treatments for myopia management around the world.",
author = "Xintong Li and Friedman, {Ilana B.} and Medow, {Norman B.} and Cheng Zhang",
year = "2017",
month = "5",
day = "1",
doi = "10.3928/01913913-20170106-01",
language = "English (US)",
volume = "54",
pages = "142--148",
journal = "Journal of Pediatric Ophthalmology and Strabismus",
issn = "0191-3913",
publisher = "Slack Incorporated",
number = "3",

}

TY - JOUR

T1 - Update on orthokeratology in managing progressive myopia in children

T2 - Efficacy, mechanisms, and concerns

AU - Li, Xintong

AU - Friedman, Ilana B.

AU - Medow, Norman B.

AU - Zhang, Cheng

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Myopia is an important public health issue, and high myopia may lead to severe complications if left untreated. Orthokeratology lenses, worn overnight to reshape the cornea, are one of many recent modalities used to slow down the progression of myopia in children. This treatment has been proven successful, as evidenced by decreased spherical refractive error and axial length relative to the control at interval follow-up ranging from 6 months to 5 years. In this systematic review, the authors collected published controlled studies that analyzed the efficacy of orthokeratology lens wear and calculated longitudinal relative changes in axial length, revealing a weighted average of -45.1% change in axial length at the 2-year follow-up. The exact mechanism by which orthokeratology lenses reduce myopia progression is unknown, but research shows that the corneal reshaping decreases peripheral hyperopic defocus and therefore increases peripheral myopic defocus to likely reduce stimuli for axial elongation and subsequent development of myopia. Use of orthokeratology lenses is generally safe, but cases of associated infectious keratitis may have a higher incidence of virulent organisms such as Pseudomonas, Acanthamoeba, and antibacterial-resistant strains of Staphylococcus, partially due to the required overnight use of these lenses. Orthokeratology is regarded as one of the most effective non-pharmacologic measures to slow progression of myopia in children and, with regular follow-up to ensure safety, continues to be one of the most effective treatments for myopia management around the world.

AB - Myopia is an important public health issue, and high myopia may lead to severe complications if left untreated. Orthokeratology lenses, worn overnight to reshape the cornea, are one of many recent modalities used to slow down the progression of myopia in children. This treatment has been proven successful, as evidenced by decreased spherical refractive error and axial length relative to the control at interval follow-up ranging from 6 months to 5 years. In this systematic review, the authors collected published controlled studies that analyzed the efficacy of orthokeratology lens wear and calculated longitudinal relative changes in axial length, revealing a weighted average of -45.1% change in axial length at the 2-year follow-up. The exact mechanism by which orthokeratology lenses reduce myopia progression is unknown, but research shows that the corneal reshaping decreases peripheral hyperopic defocus and therefore increases peripheral myopic defocus to likely reduce stimuli for axial elongation and subsequent development of myopia. Use of orthokeratology lenses is generally safe, but cases of associated infectious keratitis may have a higher incidence of virulent organisms such as Pseudomonas, Acanthamoeba, and antibacterial-resistant strains of Staphylococcus, partially due to the required overnight use of these lenses. Orthokeratology is regarded as one of the most effective non-pharmacologic measures to slow progression of myopia in children and, with regular follow-up to ensure safety, continues to be one of the most effective treatments for myopia management around the world.

UR - http://www.scopus.com/inward/record.url?scp=85020137235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020137235&partnerID=8YFLogxK

U2 - 10.3928/01913913-20170106-01

DO - 10.3928/01913913-20170106-01

M3 - Review article

C2 - 28092397

AN - SCOPUS:85020137235

VL - 54

SP - 142

EP - 148

JO - Journal of Pediatric Ophthalmology and Strabismus

JF - Journal of Pediatric Ophthalmology and Strabismus

SN - 0191-3913

IS - 3

ER -